Aryl pyridinyl thiazoles from Novartis useful for inflammatory or obstructive airways diseases Jan. 18, 2000
Respiratory disease collaboration ended by mutual agreement by Millennium and AstraZeneca Jan. 13, 2000
New nonpeptide compound AY-0068 is a potent, selective and metabolically stable tryptase inhibitor Jan. 4, 2000